Brought to you by 
Series B brings in $8.6mm for Tangent Medical Technologies
07 Jan 2013
Executive Summary
Tangent Medical Technologies Inc. has raised $8.6mm through what is believed to be its Series B venture round. There were nine undisclosed investors. The funding comes on the heels of the company gaining FDA approval of its NovaCath closed IV catheter system.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series B brings in $8.6mm for Tangent Medical Technologies
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice